FundedIQ
Biotechnology

Valencia Technologies: Funding, Investors & Team (Oct 2026)

Valencia Technologies creates neuromodulation devices for managing urinary incontinence, such as the eCoin system. This FDA-approved implantable device stimulates the tibial nerve to treat Urge Urinary Incontinence (UUI). Implanted near the ankle, the small neurostimulator provides automatic nerve stimulation in a minimally invasive procedure that does not require external devices, wires, recharging, or general anesthesia.

valenciatechnologies.com LinkedIn Valencia, United States 101-250 employees
Biotechnology Health Care Health Diagnostics Medical Device B2B
Total raised
$35.0M
Rounds
1
Latest
Undisclosed round
Feb 2025

Valencia Technologies has raised $35.0M across 1 funding round on record, the most recent an undisclosed round of $35.0M announced in Feb 2025.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Valencia Technologies Company Profile and Key Stats

Total funding raised
$35.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$35.0M in Feb 2025
Employees
101-250
reported band
Headquarters
Valencia, United States

Latest funding round on record: Feb 2025.

Valencia Technologies Funding Rounds

Date
Round
Amount
Undisclosed round
$35.0M

Valencia Technologies Founders and Leadership Team

Name
Role
Contact
Jeff Greiner
Founder
Locked

Contact details for the Valencia Technologies team: 1 of 1 has an email address on file.

Start 14-day free trial →

Valencia Technologies Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

Valencia Technologies' latest round of $35.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Valencia Technologies in Biotechnology and Valencia

Companies Similar to Valencia Technologies

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Valencia Technologies Funding FAQs

What does Valencia Technologies do?

Valencia Technologies creates neuromodulation devices for managing urinary incontinence, such as the eCoin system. This FDA-approved implantable device stimulates the tibial nerve to treat Urge Urinary Incontinence (UUI). Implanted near the ankle, the small neurostimulator provides automatic nerve stimulation in a minimally invasive procedure that does not require external devices, wires, recharging, or general anesthesia.

How much funding has Valencia Technologies raised?

Valencia Technologies has raised $35.0M across 1 round on record. The most recent is an undisclosed round of $35.0M announced in Feb 2025.

When did Valencia Technologies last raise funding?

Valencia Technologies' most recent funding round on record is an undisclosed round of $35.0M, announced in Feb 2025.

Who founded Valencia Technologies?

FundedIQ lists Jeff Greiner (Founder) at Valencia Technologies.

Where is Valencia Technologies headquartered?

Valencia Technologies is based in Valencia, California, United States.

How many employees does Valencia Technologies have?

Valencia Technologies is in the 101-250 employee band.

How does Valencia Technologies' funding compare to other Biotechnology startups?

Valencia Technologies' latest round of $35.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Valencia Technologies Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Valencia Technologies is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.